These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7260913)

  • 1. Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions.
    Shu S; Steerenberg PA; Hunter JT; Evans CH; Rapp HJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3499-506. PubMed ID: 7260913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; van de Plas MM; Steerenberg PA; Kruizinga W; Ruitenberg EJ
    J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of immunological eradication of a syngeneic guinea pig tumor: participation of a component(s) of recipient origin in the expression of systemic adoptive immunity.
    Shu S; Fonseca LS; Kato H; Zbar B
    Cancer Res; 1983 Jun; 43(6):2637-43. PubMed ID: 6342756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell involvement in adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; Steerenberg PA; van de Plas MM; Kruizinga W; Ruitenberg J
    J Natl Cancer Inst; 1985 Sep; 75(3):483-9. PubMed ID: 3875751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of immunologic eradication of a syngeneic guinea pig tumor. I. Quantitative analysis of adoptive immunity.
    Shu S; Hunter JT; Rapp HJ; Fonseca LS
    J Natl Cancer Inst; 1982 Apr; 68(4):673-80. PubMed ID: 6951081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of tumor incidence by oncofetal products in a syngeneic hepatoma cell-spleen cell model.
    Mizejewski GJ; Macario AL
    Neoplasma; 1983; 30(1):23-34. PubMed ID: 6188067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ability of tumor-unique and cross-reactive antigen(s) on two murine hepatoma cell lines to induce Lyt-1+2- T cells responsible for in vivo protective immunity.
    Shima J; Yoshioka T; Kosugi A; Ogata M; Fujiwara H; Hamaoka T; Ueda S; Kato S
    Biken J; 1987 Mar; 30(1):1-8. PubMed ID: 2445335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo protection against syngeneic Gross virus-induced lymphoma in rats: comparison with in vitro studies of cell-mediated immunity.
    Glaser M; Lavrin DH; Herberman RB
    J Immunol; 1976 Jun; 116(6):1507-11. PubMed ID: 58036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New monoclonal antibodies specific for the guinea pig line 10 hepatocarcinoma.
    Kataoka T; Chiba J; Ohnuki T; Nemoto K; Tokunaga T
    Jpn J Cancer Res; 1987 Sep; 78(9):960-7. PubMed ID: 3117752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
    Boyer CM; Kreider JW; Bartlett GL
    Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immunogenicity of line 10 guinea pig hepatocarcinoma cells after culture.
    Correll LL; Nielsen LD; Kelleher PJ; Harbell JW; Minden P
    J Natl Cancer Inst; 1983 Dec; 71(6):1343-6. PubMed ID: 6581367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection of retrovirus-infected tumor cells in guinea pigs: effect on bystander tumor cells.
    Nagai A; Zbar B; Terata N; Hovis J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5783-8. PubMed ID: 6315216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturally soluble tumor antigens from guinea pig hepatomas: isolation and partial characterization.
    Detrick-Hooks B; Smith HG; Bast RC; Dunkel VC; Borsos T
    J Immunol; 1976 May; 116(5):1324-31. PubMed ID: 178795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of growth of guinea pig line-10 hepatocarcinoma. II. Effect of passive transfer of xenogeneic and syngeneic antibodies and normal lymphoid cells.
    Minden P; Brunda MJ; Ferguson HR
    J Immunol; 1978 Nov; 121(5):1933-8. PubMed ID: 712072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen.
    Hwang KM; Foon KA; Cheung PH; Pearson JW; Oldham RK
    Cancer Res; 1984 Oct; 44(10):4578-86. PubMed ID: 6467213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major-histocompatibility-complex-class-II-positive cells and interleukin-2-dependent proliferation of immune T cells are required to reject carcinoma cells in the guinea pig.
    Steerenberg PA; De Jong WH; Geerse E; Beuvink A; Scheper RJ; Den Otter W; Ruitenberg EJ
    Cancer Immunol Immunother; 1990; 31(5):297-304. PubMed ID: 2376047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Splenocyte functional activity in mice growing the syngeneic transplantable hepatoma 22a].
    Kiseleva EP; Malygin AM
    Tsitologiia; 1984 Dec; 26(12):1409-15. PubMed ID: 6335612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of autosensibilization of lymphoid cells in genesis of antitumor resistance.
    Malygin AM; Fel VJ
    Neoplasma; 1979; 26(4):429-37. PubMed ID: 522915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.